REPORT ID 7136

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Research Report 2017

Publish Date
2-Nov-17
Pages
114
Format
Electronic (PDF)

In this report, the global B-Cell Maturation Antigen(BCMA) Targeted Therapies market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of B-Cell Maturation Antigen(BCMA) Targeted Therapies in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global B-Cell Maturation Antigen(BCMA) Targeted Therapies market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Transposagen Biopharmaceuticals
    Sutro Biopharma
    Malin Corporation
    Eureka Therapeutics
    firstVentury Equity
    Five Prime Therapeutics
    Credit Suisse Securities
    Dana-Farber Cancer Institute
    Deerfield Partners
    Onyx Pharmaceuticals
    Juno Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Bispecific Antibodies
    Antibody Drug Conjugates
    Chimeric Antigen Receptor T-Cells
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Liver Cancer
    Respiratory Cancer
    Brain Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Research Report 2017
1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Overview
    1.1 Product Overview and Scope of B-Cell Maturation Antigen(BCMA) Targeted Therapies
    1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment by Type (Product Category)
        1.2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Market Share by Type (Product Category) in 2016
        1.2.3 Bispecific Antibodies
        1.2.4 Antibody Drug Conjugates
        1.2.5 Chimeric Antigen Receptor T-Cells
    1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Segment by Application
        1.3.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Liver Cancer
        1.3.3 Respiratory Cancer
        1.3.4 Brain Cancer
        1.3.5 Others
    1.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market by Region (2012-2022)
        1.4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of B-Cell Maturation Antigen(BCMA) Targeted Therapies (2012-2022)
        1.5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue Status and Outlook (2012-2022)
        1.5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production Status and Outlook (2012-2022)

2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Competition by Manufacturers
    2.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production and Share by Manufacturers (2012-2017)
    2.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Share by Manufacturers (2012-2017)
    2.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Base Distribution, Sales Area and Product Type
    2.5 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Competitive Situation and Trends
        2.5.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Concentration Rate
        2.5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity and Market Share by Region (2012-2017)
    3.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production and Market Share by Region (2012-2017)
    3.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption by Region (2012-2017)
    4.2 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption, Export, Import (2012-2017)
    4.3 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption, Export, Import (2012-2017)
    4.4 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption, Export, Import (2012-2017)
    4.5 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption, Export, Import (2012-2017)
    4.7 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption, Export, Import (2012-2017)

5 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue (Value), Price Trend by Type
    5.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production and Market Share by Type (2012-2017)
    5.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Market Share by Type (2012-2017)
    5.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price by Type (2012-2017)
    5.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production Growth by Type (2012-2017)

6 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Analysis by Application
    6.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption and Market Share by Application (2012-2017)
    6.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturers Profiles/Analysis
    7.1 Transposagen Biopharmaceuticals
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Transposagen Biopharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 Sutro Biopharma
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Sutro Biopharma B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Malin Corporation
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Malin Corporation B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Eureka Therapeutics
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Eureka Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 firstVentury Equity
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 firstVentury Equity B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Five Prime Therapeutics
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Five Prime Therapeutics B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 Credit Suisse Securities
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Credit Suisse Securities B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 Dana-Farber Cancer Institute
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 Dana-Farber Cancer Institute B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Deerfield Partners
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Deerfield Partners B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Onyx Pharmaceuticals
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 B-Cell Maturation Antigen(BCMA) Targeted Therapies Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Onyx Pharmaceuticals B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview
    7.11 Juno Therapeutics

8 B-Cell Maturation Antigen(BCMA) Targeted Therapies Manufacturing Cost Analysis
    8.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of B-Cell Maturation Antigen(BCMA) Targeted Therapies

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 B-Cell Maturation Antigen(BCMA) Targeted Therapies Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of B-Cell Maturation Antigen(BCMA) Targeted Therapies Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Market Forecast (2017-2022)
    12.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Price and Trend Forecast (2017-2022)
    12.2 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global B-Cell Maturation Antigen(BCMA) Targeted Therapies Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach